Meet Becton, Dickinson and Co. (NYSE: BDX): An Innovative Medical Device Company with a Steadily Growing Dividend

Becton, Dickinson and Company (BD) is an American company that produces and sells medical equipment. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD is present in nearly 50 countries and employs more than 29,000 people. In fiscal year 2009, 60% of BD's sales came from markets outside the United States. The company's customers include primarily hospitals, laboratories, and researchers. BD was one of the first companies to sell syringes in the United States. (Source: Wikipedia)

With a predominant rate of exports, BD fits perfectly with our diversification strategy against the dollar. The volatility of the title compared to the CHF is thus very correct, at 9.01%. Having purchased some BDX In April 2010, we still lost 6%, while we would have gained 4.3% with the euro as the reference currency. Despite this, like Warren Buffett, we remain very confident in Becton Dickinson, which our algorithm still considers a long position.

Although the dividend yield is modest, at 1.68%, BD has increased its distributions at a steady pace of 13,56% per yearThe company has also increased its dividend since 38 consecutive years. But one of the most remarkable qualities of the title is its distribution rate which is only 27.4%. With such figures, it is certain that Becton Dickinson will have no trouble growing its dividend for many years to come..

Finally, we cannot resist the urge to present to you the evolution of the BDX price compared to the S&P500 since 1985. Past performance is no guarantee for the future, but this graph sums up well the points discussed in this article: low volatility, and a impressive growth (+3,500% in 26 years)We also note the defensive nature of the title which calmly crossed the double bottom of the decade 2000-2010.